Insider Transactions in Q2 2022 at Cytosorbents Corp (CTSO)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 21
2022
|
Vincent Capponi President and COO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.45%
|
$2,000
$1.8 P/Share
|
Jun 16
2022
|
Phillip P. Chan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,221
+0.29%
|
$2,221
$1.85 P/Share
|
Jun 16
2022
|
Vincent Capponi President and COO |
BUY
Open market or private purchase
|
Direct |
3,000
+0.67%
|
$6,000
$2.0 P/Share
|
Jun 09
2022
|
Phillip P. Chan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
16,000
+2.05%
|
$32,000
$2.17 P/Share
|
Jun 06
2022
|
Kathleen P. Bloch Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
8,700
+20.52%
|
$8,700
$1.9 P/Share
|
May 23
2022
|
Vincent Capponi President and COO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.38%
|
$10,000
$2.03 P/Share
|
May 18
2022
|
Michael G. Bator Director |
BUY
Open market or private purchase
|
Direct |
11,000
+2.23%
|
$22,000
$2.2 P/Share
|
May 16
2022
|
Edward Raymond Jones Director |
BUY
Open market or private purchase
|
Direct |
1,676
+2.02%
|
$3,352
$2.24 P/Share
|
May 11
2022
|
Alan D. Sobel Director |
BUY
Open market or private purchase
|
Direct |
10,000
+5.83%
|
$20,000
$2.01 P/Share
|
May 06
2022
|
Al Kraus Director |
BUY
Open market or private purchase
|
Direct |
5,000
+3.7%
|
$5,000
$1.96 P/Share
|
Apr 05
2022
|
Jiny Kim Director |
BUY
Grant, award, or other acquisition
|
Direct |
69,300
+50.0%
|
-
|